摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(1,2-苯并异噻唑-3-基)-1-哌嗪羧酸叔丁酯 | 131779-46-9

中文名称
4-(1,2-苯并异噻唑-3-基)-1-哌嗪羧酸叔丁酯
中文别名
——
英文名称
1,1-dimethylethyl 4-(1,2-benzisothiazol-3-yl)-1-piperazinecarboxylate
英文别名
3-(4-boc-piperazinyl)-1,2-benzoisothiazole;1,1-dimethylethyl 4-(1,2-benzisothiazol-3-yl)-1piperazinecarboxylate;tert-Butyl 4-(benzo[d]isothiazol-3-yl)piperazine-1-carboxylate;tert-butyl 4-(1,2-benzothiazol-3-yl)piperazine-1-carboxylate
4-(1,2-苯并异噻唑-3-基)-1-哌嗪羧酸叔丁酯化学式
CAS
131779-46-9
化学式
C16H21N3O2S
mdl
MFCD09038666
分子量
319.428
InChiKey
SVEGEVBKWFQUFE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    402.0±45.0 °C(Predicted)
  • 密度:
    1.244±0.06 g/cm3(Predicted)
  • 溶解度:
    扩张型心肌病

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    22
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    73.9
  • 氢给体数:
    0
  • 氢受体数:
    5

SDS

SDS:40727aef07e2b82981941c6315d794cc
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Synthesis and biological activity of the putative metabolites of the atypical antipsychotic agent tiospirone
    摘要:
    Putative oxidative metabolites of the lead antipsychotic agent tiospirone (1) were synthesized to assist in the identification of the authentic metabolic products found in human urine samples. Thus far, six authentic metabolites have been correlated to the synthetic species. 4a The putative metabolites were further examined in vitro to assess their central nervous system therapeutic potential. SAR analysis of these derivatives indicates that hydroxyl substitution, particularly in the azaspirodecanedione region of the molecule, diminishes the dopamine D-2 affinity of the species without significantly altering the serotonin type-1A and type-2 interactions. In addition, an increase in alpha-1-adrenergic affinity appears to be linked to the attenuation of effects at the dopamine receptors. The biological profile of the 6-hydroxytiospirone metabolite 42 was exemplary in these respects and the in vivo actions of this compound suggest potent antipsychotic potential with a minimal liability for extrapyramidal side effects (EPS). While compound 42 has been unambiguously characterized as an actual human metabolite of tiospirone, the role of 42 in the observed antipsychotic activity of the parent drug, if any, has not yet been determined.
    DOI:
    10.1021/jm00115a024
  • 作为产物:
    描述:
    tert-butyl 4-(4-chloro-1,2,5-thiadiazol-3-yl)piperazine-1-carboxylate 在 cesium fluoride 、 potassium hydroxide 作用下, 以 四氢呋喃二甲基亚砜 为溶剂, 反应 4.0h, 生成 4-(1,2-苯并异噻唑-3-基)-1-哌嗪羧酸叔丁酯
    参考文献:
    名称:
    基于芳烃的途径取代苯并异噻唑
    摘要:
    使用由相应的2-(三甲基甲硅烷基)芳基三氟甲磺酸酯氟化物生成的芳烃与3-羟基-4-氨基噻二唑的组合导致选择性地形成3-氨基取代的苯并[ d ]异噻唑。可以改变芳烃前体和噻二唑的取代方式,并以高至优异的产率获得目标杂环。在所有情况下,使用3-羟基-4-氨基噻二唑都会在产物杂环中引入氨基取代基。
    DOI:
    10.1021/acs.orglett.5b02347
点击查看最新优质反应信息

文献信息

  • Metabolites and prodrug formulations of
    申请人:Bristol-Myers Company
    公开号:US04956368A1
    公开(公告)日:1990-09-11
    Various metabolites and prodrug formulations of 8-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]-8-azaspiro[4.5]deca ne-7,9-dione which are particularly useful in the treatment of psychotic disorders, especially derivatives thereof which have been oxygenated at specified sites about the original structure, rearranged compounds, and prodrug formulations of these species. One particularly desired group of compounds have the general Formula I where ##STR1## R.sup.1 is hydrogen, hydroxyl, alkoxy, acyloxy and oxo; R.sup.2 is hydrogen, methyl, hydroxyl, alkoxy, and acyloxy; R.sup.3 is hydrogen, hydroxyl, and methoxy: R.sup.4 is hydrogen, methyl and oxo; and X is S, SO, and SO.sub.2.
    8-[4-[4-(1,2-苯并异噻唑-3-基)-1-哌嗪基]丁基]-8-氮杂螺[4.5]癸烷-7,9-二酮的各种代谢产物和前药制剂,特别适用于治疗精神疾病,特别是在原始结构的指定位置被氧化的衍生物,重排的化合物以及这些物种的前药制剂。一组特别理想的化合物具有通式I,其中##STR1## R.sup.1是氢、羟基、烷氧基、酰氧基和羰基;R.sup.2是氢、甲基、羟基、烷氧基和酰氧基;R.sup.3是氢、羟基和甲氧基;R.sup.4是氢、甲基和羰基;X是S、SO和SO
  • US4956368A
    申请人:——
    公开号:US4956368A
    公开(公告)日:1990-09-11
  • Synthesis and biological activity of the putative metabolites of the atypical antipsychotic agent tiospirone
    作者:Joseph A. Cipollina、Edward H. Ruediger、James S. New、Mary E. Wire、Timothy A. Shepherd、David W. Smith、Joseph P. Yevich
    DOI:10.1021/jm00115a024
    日期:1991.11
    Putative oxidative metabolites of the lead antipsychotic agent tiospirone (1) were synthesized to assist in the identification of the authentic metabolic products found in human urine samples. Thus far, six authentic metabolites have been correlated to the synthetic species. 4a The putative metabolites were further examined in vitro to assess their central nervous system therapeutic potential. SAR analysis of these derivatives indicates that hydroxyl substitution, particularly in the azaspirodecanedione region of the molecule, diminishes the dopamine D-2 affinity of the species without significantly altering the serotonin type-1A and type-2 interactions. In addition, an increase in alpha-1-adrenergic affinity appears to be linked to the attenuation of effects at the dopamine receptors. The biological profile of the 6-hydroxytiospirone metabolite 42 was exemplary in these respects and the in vivo actions of this compound suggest potent antipsychotic potential with a minimal liability for extrapyramidal side effects (EPS). While compound 42 has been unambiguously characterized as an actual human metabolite of tiospirone, the role of 42 in the observed antipsychotic activity of the parent drug, if any, has not yet been determined.
  • An Aryne-Based Route to Substituted Benzoisothiazoles
    作者:Yiding Chen、Michael C. Willis
    DOI:10.1021/acs.orglett.5b02347
    日期:2015.10.2
    The combination of arynes, generated using fluoride from the corresponding 2-(trimethylsilyl)aryl triflates, and 3-hydroxy-4-aminothiadiazoles leads to the selective formation of 3-amino-substituted benzo[d]isothiazoles. Variation of the substitution pattern of the aryne precursor, and of the thiadiazole, is possible, with the target heterocycles being obtained in good to excellent yields. In all cases
    使用由相应的2-(三甲基甲硅烷基)芳基三氟甲磺酸酯氟化物生成的芳烃与3-羟基-4-氨基噻二唑的组合导致选择性地形成3-氨基取代的苯并[ d ]异噻唑。可以改变芳烃前体和噻二唑的取代方式,并以高至优异的产率获得目标杂环。在所有情况下,使用3-羟基-4-氨基噻二唑都会在产物杂环中引入氨基取代基。
查看更多